Kojin Therapeutics

Kojin Therapeutics is a biotechnology company focused on developing novel treatments for a variety of diseases, including cancer, cardiovascular, immunologic, hepatic, and degenerative conditions. Their approach is rooted in the discovery of ferroptosis, a unique form of programmed cell death distinct from traditional processes. This discovery forms the foundation of their drug discovery platform, which integrates computational chemistry, structural biology, and other disciplines to develop small-molecule therapeutics specifically modulating ferroptosis.

Kojin's mission is to harness the power of ferroptosis biology to create groundbreaking medicines. They are actively pursuing several validated ferroptosis targets across a range of oncology indications, with their lead program focusing on glutamate-cysteine-ligase (GCL). Beyond oncology, Kojin is exploring the role of ferroptosis in other disease pathologies, aiming to develop both inducers and inhibitors of regulated cell death, thereby offering a diverse approach to tackling complex medical challenges.

Kojin Therapeutics offers flexible paid time off benefits, paid company holidays, and a winter break during the last week of the year. Their culture is described as open, transparent, and inclusive, suggesting a workplace that values employee well-being and fosters a positive work-life balance.

Kojin Therapeutics offers a competitive benefits package for its employees, including multiple health plan options with HSA compatibility, dental and vision insurance, a health savings account with partial company funding, life and AD&D insurance, short-term and long-term disability insurance, bereavement, legal, and financial services. In addition, employees receive a competitive base salary, stock option grants, subsidized parking or transportation passes, a 401(k) with pre-tax and Roth contributions, and flexible paid time off benefits.

Kojin Therapeutics is a biopharmaceutical company pioneering cell-state and ferroptosis biology to develop first-in-class treatments for cancer, cardiovascular, immunologic, hepatic, and degenerative diseases. Their drug discovery platform integrates computational chemistry, structural biology, chemical biology, and target-informed screening to create small-molecule therapeutics that specifically modulate ferroptosis, a newly discovered form of programmed cell death with potential to address a wide range of diseases.

Kojin Therapeutics fosters a collaborative and supportive work environment, encouraging its team of passionate scientists to flourish. The company values open communication and transparency, providing opportunities for its employees to publish and present their research, attend scientific meetings, and pursue career growth. Kojin's modern and friendly office spaces, along with progressive biology and chemistry labs, are designed to inspire innovation and teamwork.

Kojin Therapeutics promotes a diverse and inclusive workplace, fostering a respectful environment where scientists are encouraged to publish and present research. They offer competitive benefits, including flexible PTO, subsidized parking, and attendance at scientific meetings, along with opportunities for career growth. The company also emphasizes an open and transparent culture, valuing different perspectives and experiences.